▼ SELL
10b5-1 Plan
$ Value
$227K
Shares
5,369
Price
$42
Filed
Aug 18
Insider
Name
Sensenig Bethany
Title
—
CIK
0001899935
Roles
Director
Transaction Details
Transaction Date
2025-08-14
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
Transaction made pursuant to a 10b5-1 trading plan adopted May 15, 2025. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.88 to $42.52. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.